Interference With ERK-dimerization at the Nucleocytosolic Interface Targets Pathological ERK1/2 Signaling Without Cardiotoxic Side-Effects
Nature Communications - United Kingdom
doi 10.1038/s41467-020-15505-4
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2020
Authors
Publisher
Springer Science and Business Media LLC